City
Epaper

India to strengthen R&D, industrial ecosystem to prepare for future pandemic: Jitendra Singh

By IANS | Updated: March 10, 2025 18:16 IST

New Delhi, March 10 Amid the looming threat of zoonotic spillovers, Union Minister Dr. Jitendra Singh on Monday ...

Open in App

New Delhi, March 10 Amid the looming threat of zoonotic spillovers, Union Minister Dr. Jitendra Singh on Monday said that India will strengthen its research and development capacities as well as industrial ecosystem to prepare for future pandemics.

The Minister of State (Independent Charge) for Science and Technology said this while discussing NITI Aayog’s report on “future pandemic preparedness". The report outlines the action pathways to deploy medical countermeasures within 100 days of any future pandemic outbreak.

"India’s deep R&D capacities and the industrial ecosystem will be further strengthened to be ready to respond to any future pandemic,” Singh said.

The Minister also discussed how to mobilise the research and development team and infrastructure along with the industry to work on potential pathogens and prototype vaccines in a strategic, scientific, and proactive way across departments and other stakeholders.

“India’s inter-sectoral One Health Mission has already revamped the pandemic surveillance systems for potential outbreaks,” he said. The report prepared by an Expert Group constituted by NITI Aayog covers recommendations on future pandemic preparedness with a special focus on developing medical countermeasures, specifically, diagnostics, vaccines, and therapeutics.

It outlines the action pathways to deploy medical countermeasures within 100 days of any future pandemic outbreak. This would require scaling manufacturing capacities, creating forward and backward linkages, enabling regulatory systems, and demonstrating capabilities.

It was noted how India administered more than 220 crore doses of vaccines that were indigenously developed to its citizens during the recent Covid-19 pandemic. The country also shared vaccines with more than 100 countries.

“Indian vaccines utilised practically all the platforms including mRNA, DNA, Adeno-viral and inactivated virus systems. Drugs made in India were exported across the world. Nearly 250 made-in-India Covid diagnostic tests were approved. All this demonstrates our strong scientific-industrial potential,” Singh said.

Singh attributed these to “the coordinated and collective effort across the departments with a whole of government approach”.

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Open in App

Related Stories

TechnologyIndia offers tremendous opportunities, Piyush Goyal tells Singapore-based investors

Other SportsPVL 2025: Bengaluru Torpedoes look to build momentum against Kolkata Thunderbolts

BusinessIndia offers tremendous opportunities, Piyush Goyal tells Singapore-based investors

NationalIndia offers tremendous opportunities, Piyush Goyal tells Singapore-based investors

BusinessTata Capital IPO to open on October 6; 98% of loan book under Rs 1 crore, says MD

Health Realted Stories

HealthMP orders blanket ban on toxic 'Coldrif' syrup sale, all quantities to be disposed immediately

HealthAfter nine paediatric deaths; MP bans 'lethal' cough syrup, urges TN govt to initiate probe

HealthOver 4.4 lakh chikungunya disease cases, 155 deaths reported worldwide in 2025: WHO

HealthLong Covid patients more likely to suffer from unusual heart rhythm disorder

HealthVenugopal calls on Kharge, wishes him speedy recovery